Table II.
Comparison of clinical efficacy [n/%].
| Group | Number of Patients | Sputum Culture-Negative Conversion Rate | Chest Lesion Absorption Rate | Cavity Closure Rate | |||
|---|---|---|---|---|---|---|---|
|
| |||||||
| n | 6 months post-treatment | 12 months post-treatment | 6 months post-treatment | 12 months post-treatment | 6 months post-treatment | 12 months post-treatment | |
| Tα1 | 60 | 32 (53.33) | 44 (73.33) | 36 (60.00) | 48 (80.00) | 30 (50.00) | 46 (76.67) |
| Control | 60 | 18 (30.00) | 26 (43.33) | 22 (36.67) | 30 (50.00) | 16 (26.67) | 28 (30.00) |
| χ2 | 3.360 | 5.554 | 3.270 | 5.934 | 3.455 | 5.711 | |
| P | >0.05 | <0.05 | >0.05 | <0.05 | >0.05 | <0.05 | |